§ BIOTECHNOLOGY
USD · Biotechnology

ABEO

ABEONA THERAPEUTICS INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
75 increased/new, 36 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Nantahala Capital Management, LLC5.0M0.8%+1%
BlackRock3.2M0.0%+1%
AIGH Capital Management LLC3.1M1.9%+55%
Cable Car Capital, LP3.0M4.7%+20%
SUVRETTA CAPITAL MANAGEMENT, LLC2.7M0.3%±0%
VANGUARD CAPITAL MANAGEMENT LLC2.2Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for ABEO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER18.5% · 0 holders
OTHER58.9% · 68 holders
DEALER / BANK9.4% · 16 holders
PASSIVE / INDEX8.6% · 7 holders
TACTICAL / MACRO2.4% · 3 holders
SYSTEMATIC / QUANT1.5% · 3 holders
QUALITY / COMPOUNDER0.6% · 6 holders
ACTIVIST0.2% · 1 holder
INCOME / DEFENSIVE0.1% · 4 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for ABEO in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention ABEO yet.